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Background: Dilated cardiomyopathy is myocardial disease characterized by dilatation and impaired contraction of
the left ventricle or both left and right ventricle. The majority of these cases are secondary to coronary artery disease,
hypertension and valvular cardiomyopathy. Patients diagnosed with dilated cardiomyopathy are further clinically
evaluated for evidence of familial history of the disease. Those families have shown to have genetic predisposition to
dilated cardiomyopathy; thus, currently there is no available single genetic test that allows comprehensive testing of
all causative genes. We report a Kuwaiti case of dilated cardiomyopathy that was diagnosed at young age. The patient
clinical presentation pointed out to the fact that this was a familial disease. This case is the first reported in Kuwait
clinically presented with familial dilated cardiomyopathy implying a genetic susceptibility factor to be further
investigated within the at-risk family members.
Case presentation: 23-year-old Arab ethnicity Kuwaiti male with strong family history of dilated cardiomyopathy was
admitted witnessed with sudden cardiac death. The patient presented with sudden arrhythmic death and survived
with permanent anoxic brain injury. Transthoracic echocardiography revealed dilated cardiomyopathy with severe
global left ventricular systolic dysfunction. After thorough investigation, the patient shown to have strong family history
of dilated cardiomyopathy.
Conclusion: Familial dilated cardiomyopathy is poorly documented in Kuwait. We present this case with future plan to
study the genetic map of his family.
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According to the World Health Organization (WHO),
cardiovascular diseases are the number one cause of death
accounting for 30 percent (17.5 million) of all deaths
worldwide [1]. Cardiovascular diseases are caused by
disorders of the heart and blood vessels, they includes
coronary heart disease (heart attacks), cerebrovascular
disease (stroke), raised blood pressure (hypertension),
peripheral artery disease, rheumatic heart disease, con-
genital heart disease and heart failure. The WHO defined
cardiomyopathies as diseases of the heart muscle. They
classified them due to their etiology into, cardiomyopa-
thies with unknown causes, and cardiomyopathies from
cardiac dysfunction (sudden cardiac arrest) due to known* Correspondence: maisa.mahmoud@dasmaninstitute.org
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unless otherwise stated.cardiovascular disorders such as hypertension, ischemic
heart disease, or valvular disease [2] (See Tables 1 and 2).
Cardiac deaths are classified as sudden or non-sudden,
sudden cardiac death is defined as death occurring sud-
denly and unexpectedly in a patient who is otherwise
stable prior to the event [3,4]. Sudden cardiac death is
caused by ventricular tachycardia or fibrillation and may
be aborted with an implantable cardioverter defibrillator.
Among young adults (18–35 years), sudden cardiac death
most commonly results from a previously undiagnosed
congenital or hereditary condition such as coronary artery
anomalies and inherited cardiomyopathies [5]. They are
classified into (i) witnessed deaths, if death occurred
within 1 hour after the onset of new symptoms or as (ii)
un-witnessed deaths if the patient was seen alive and
stable during the previous 24-hours. On the other hand, if
the sequence of events is consistent with sudden death
but a specific cause of death other than arrhythmia is
confirmed; the death is classified as non-sudden. A carefulal. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
Table 1 Classification criteria of primary cardiomyopathy
according to the American heart association and the
European society of cardiology
Primary cardiomyopathy
Genetic Mixed* Acquired
• HCM* • DCM* • Inflammatory
(myocarditis)













• Ion channel Disorders
(LQTS, Brugada, SQTS,
CVPT, Asian SUNDS)
*HCM: Hypertrophic Cardiomyopathy, *DCM: Dilated Cardiomyopathy,
*ARVC/D: Arrhythmogenic Right Ventricular Cardiomyopathy/Dysplasia,
*LV/NC: Left Ventricular Noncompaction Cardiomyopathy.
Table 2 Classification criteria of secondary
cardiomyopathy according to the American heart
association and the European society of cardiology
Secondary cardiomyopathy
Infiltrative • Amyloidosis (primary familial autosomal





• Glycogen storage disease (type II, Pompe)
Toxicity • Drugs, heavy metals, alcohol
Endomyocardial • Hyperesinophilic syndrome
(Loeffler’s endocarditis)
Inflammatory • Sarcoidosis











• Duchenne-Becher muscular dystrophy




Nutritional deficiencies • Beriberi (thiamine), pellagra, scurvy,
selenium, carnitine, kwashiorkor
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cardiography and cardiac imaging, are essential to diag-
nose conditions associated with sudden cardiac death [6].
Case presentation
In March 2003, a 23-year-old Arab ethnicity Kuwaiti male
with a strong family history of dilated cardiomyopathy
presented to a specialized neurology hospital with dizzy
spells and feet parasthesia. He was given intravenous
methylprednisolone for 3 days for probable multiple scler-
osis and was booked electively for a magnetic resonance
imaging (MRI) of the brain. On March 23rd 2003, he had
a witnessed sudden cardiac arrest and suddenly collapsed
when he was at an automated banking teller machine. The
paramedic personnel were at the scene within 5 minutes
of the call, endotracheal intubation was carried out as well
as an intra-tracheal atropine and adrenalin was given at
the scene. A cardiac monitor was attached and revealed
ventricular fibrillation (Figure 1), and thus was electrically
cardioverted 3 times (200 J, 300 J and 360 J) until reverted
to sinus rhythm. The resuscitation procedure including
the transit time to hospital was around 30 minutes. On
arrival to intensive care unit (ICU), he had a heart rate of
150 beats per minute and a blood pressure of 110/70 mm/
Hg. Electrocardiography (ECG) revealed sinus rhythm
with incomplete Left bundle branch block (LBBB) and
non-specific ST-T wave changes (Figure 2). A transtho-
racic echocardiography showed a mildly dilated left
ventricular (LV) with severe global LV systolic dysfunction
with an estimated Left Ventricular Ejection Fraction
(LVEF) of 20 to 25% (Figure 3). An echocardiogram wasdone 6 months prior to the hospital admission and LV
systolic function reported to be normal. During his ICU
stay, he had recurrent convulsions, which were controlled
with epanutin and clonazepam. Computed tomography
scan (CTS) of the head showed a small infarct (probably
embolic) in the right centrum semiovale adjacent to the
body of the right lateral ventricle. An electroencephalo-
graph (EEG) was performed and this revealed diffuse
Figure 1 Ventricular fibrillation of the patient using a cardiac monitor.
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a battery of laboratory investigations including liver
function test, renal function test, complete blood count
and thyroid function test and these were all within
normal limits. Later on, he had a transient rise in liver
enzymes and this was found to be secondary to hepatic
hypo-perfusion (hepatitis viral screening, auto-immune
screening and serum copper tests were all normal).
Eventually a tracheostomy was performed and a naso-
gastric tube fed him. His neurological condition showed
a slow but steady improvement over a course of 3 months
and regained consciousness, with spontaneous breathing
and thus the tracheostomy was closed. However, he was
left mentally handicapped with sphincteric incontinence
and was referred to the rehabilitation hospital forFigure 2 Electrocardiography revealed sinus rhythm with incompleteaggressive physiotherapy. During his follow up, he was
treated medically with anti-failure and antiepileptic
drugs (digoxin, revotril, epanutin, zestril, lasix, zantac
and amiodarone). However, he continued to show non-
sustained ventricular tachycardia on a 24-hour holter
monitor (Figure 4). Eventually, he had an automated
implantable cardioverter-defibrillator (AICD) inserted
in 2004 and his functional status significantly improved
and he is still alive. He developed amiodarone induced
thyroiditis with hyperthyroidism, Thyroid test, FT4 =
15.29 (Normal = 5.69-13.44) and Thyroid stimulating
hormone, TSH = 0.03 (Normal = 0.43-4.1) which was
proven by a positive thyroid scan. His thyroid function
normalized following the discontinuation of amiodarone.
Investigations of his family history revealed that his fatherleft bundle branch block and non-specific ST-T wave changes.
Figure 3 A transthoracic echocardiography showed a mildly dilated left ventricular with severe global left ventricular systolic dysfunction
with an estimated left ventricular ejection fraction of 20 to 25%.
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was treated with AICD, but had a sudden cardiac death a
few years ago while he was waiting for cardiac transplant-
ation. In addition, two of his sisters had pacemakers
inserted, and one of his paternal uncles died suddenly at
the age of 25 years. Family pedigree is shown in (Figure 5).
Discussion
Though the American heart association (AHA) and the
European society of cardiology (ESC) defined and classified
cardiomyopathies differently [7,8]; however, both organiza-
tions have agreed on general classification systems into
primary and secondary cardiomyopathies (Figures 6 and
7). While the AHA considers ion channelopathies as one
of the cardiomyopathies, the ESC does not consider ionFigure 4 The patient still showing non sustained ventricular tachycarchannelopathies as an accepted cardiomyopathy because
genes encoding for ion channels might not result in mor-
phofunctional phenotypes. Thus, in 2013, the American
college of cardiology (ACC) and AHA defined cardiomy-
opathies as disorders characterized by morphologically
and functionally abnormal myocardium in the absence of
any other disease that is sufficient, by itself, to cause the
observed phenotype [9]. The majority of these cases are
secondary to coronary artery disease, hypertension and
valvular cardiomyopathy. The number and severity of each
of the traditional cardiovascular risk factors should be
evaluated. These risk factors must evaluate as continuous
rather than discrete variables that exert a dose-dependent
effect on coronary artery disease. Moreover, there are
novel biomarkers reflecting thrombosis, inflammation anddia on 24 hour holter monitor.
Figure 5 Pedigrees of a Kuwaiti family diagnosed with familial dilated cardiomyopathy. Squares indicate men; circles, women; crossed
symbols, deceased; highlighted symbols, diagnosed with dilated cardiomyopathy and has peacemaker; clear symbol, number of unaffected/
asymptomatic members.
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process of atherthrombosis in acute ischemic heart disease
[10]. A fourth of the cases of congestive cardiac failure are
secondary to idiopathic cardiomyopathy [11]. It is possible
that idiopathic dilated cardiomyopathy (IDC) represents a
common expression of myocardial damage that has been
produced by un-established myocardial insults [12]. The
incidence of a familial form of dilated cardiomyopathy (isFigure 6 General classification systems into primary cardiomyopathie
society of cardiology.up to 20% of all cases of DCM [13,14]. Identifying these
individuals will help the treating physician in pursuing
major changes in the clinical management or counseling
of these patients with the following recommendations:
1. Avoidance of competitive sport activity.
2. Instituting early medical treatment such as ACEi
and β blockers.s according to the American heart association and the European
Figure 7 General classification systems into secondary cardiomyopathies according to the American heart association and the European
society of cardiology.
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A. Succinyl choline or volatile anesthetics
(halothane and isoflurane) in emerinopathies
and laminopathies.
B. Statins in genetic cardiomyopathies with possible
involvement of the skeletal muscle, even when
markers of myopathy are negative.
C. Patients with mitochondrial cardiomyopathy and
epilepsy should not receive valproate because it
may cause pseudo atrophy of brain.
Here we differentiate a patient with ‘true’ IDC who
had his first-degree family members clinically screened
(history, physical examination, echocardiogram, and ECG)
to rule out familial dilated cardiomyopathy (FDC) versus
a ‘presumptive’ IDC – one who is negative for familial
disease by a careful 3–4 generation family history but
has not had family members screened beyond the
family history [15]. Our patient fulfilled the criteria for
idiopathic cardiomyopathy that had first-degree family
members with a definite diagnosis of idiopathic dilated
cardiomyopathy (IDC). Despite the evidence supporting
a genetic basis of IDC/FDC, physicians have poorly
complied with the implementation of guidelines [16].
Adherence to such guidelines would require a shift in
focus from strictly therapeutic measures for a single
patient presenting with advanced disease to the consid-
eration and assessment of DCM risk for an entire family.
This represents a major health problem in the Kuwaiti
society and the middle-eastern communities in general.
In this regard, close relative marriages are common in
these societies, which results in the cluster of pathological
genes in certain families. This is also seen in inherited
hematological disorders. Usually families affected by these
disorders end up having to live with the potential tragedy
of losing their off springs or close relatives before their
eyes. Familial cardiomyopathy is a serious disease when
the phenotypic expression leads to severe cardiomyopathy,
and our patient represents an example of this serious dis-
ease. The patient became handicapped and lost his father,who was his caregiver. Therefore, a better understanding
the genetic basis of FDC disease in Kuwait will help med-
ical staff convince families to change the pattern of fa-
milial marriage. This change will save lives and prevent
families from going through such a devastating experience
and will help them enjoy having healthy generations. We
sought to adhere to the guidelines in pursuing the genetic
work up of the family of our patient according to the flow
diagram shown in (Figure 8). Although, numerous genes
have been reported in association with non-syndrome di-
lated cardiomyopathy [9,16], there have been no reports of
genes in association with DCM in Kuwait.
Current and future prospective
Genetic polymorphisms associated with cardiovascular
responses were reported in number of studies. Three main
genes were shown as key players in the regulation of
cardiac responses causing electrophysiology and cardiac
myocyte hypertrophy. These genes are calcium/calmodu-
lin-dependent kinase IV (CaMKIV), the G-protein-coupled
receptor kinases (GRKs) and the heptahelical G-protein-
coupled receptors (GPCRs) [17-19]. The family history of
the patient was taken and clinical screening of first-degree
relatives (who are at risk) was performed. A total of 26
blood samples from all first-degree family members were
collected, shown in the pedigree (Figure 5). The mode
of inheritance in this family appears to act through an
autosomal dominant type. Whole exome sequencing using
Hiseq technology was our method of choice to unravel the
causative genes, through a series of phenotype-genotype
filtration processes. A thorough evaluation of the patients’
relatives who are at risk will be performed to detect the
absence or presence of pathologic mutation(s).
Study limitations
The patient is assumed to have had “idiopathic cardio-
myopathy” based on the absence of secondary causes;
however, this assumption may be inaccurate. The patient
had an echocardiogram 6 months prior to hospital
admission and the left ventricular function was reported
Figure 8 Flow diagram of genetic risk assessment for patients newly diagnosed with idiopathic dilated cardiomyopathy or familial
dilated cardiomyopathy.
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in which the left ventricular systolic function deteriorates
over a number of years rather than over few months.
Hence, this case lacks the documentation of the progres-
sive nature of the disease. Moreover, he had an arrhythmic
sudden cardiac death, which required prolonged cardio-
pulmonary resuscitation. Actually, it took the paramedics
5 minutes to arrive at the scene and therefore, this pro-
longed ischemic insult may have caused myocyte necrosis
resulting in permanent left ventricular systolic dysfunc-
tion. Finally, rare causes of DCM cannot be ruled out,
as myocardial biopsy was not available in Kuwait at that
time.
Conclusions
Familial cardiomyopathies are genetic diseases and are
becoming widely recognized worldwide. The phenotypic
expression is linked to the specific causative genotype ina small percentage of dilated cardiomyopathy of unknown
etiology. To better understand the phenotypic expression,
treating physicians need to study the genetic pedigree
of affected patients with suspected inherited cardiomy-
opathy. This testing may affect the management of the
patients carrying the defective gene as well as their
first-degree relatives. However, the results of the genetic
testing must be correlated with the clinical presentation,
as it is too early to take clinical decisions based on the
genetic study alone.
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